Hepatitis B Virus and Intrahepatic Cholangiocarcinoma

REFERENCES

• de Groen P. C., Gores G. J., LaRusso N. F., Gunderson L. L., Nagorney D. M. Biliary tract cancers. N. Engl. J. Med. 1999; 341(18)1368–1378
   PubMed Web of Science ®Google Scholar
• Colombari R., Tsui W. M. Biliary tumors of the liver. Semin. Liver Dis. 1995; 15(4)402–413
   PubMed Web of Science ®Google Scholar
• Altaee M. Y., Johnson P. J., Farrant J. M., Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 1991; 68(9)2051–2055
   PubMed Web of Science ®Google Scholar
• Colombo M., Sangiovanni A. Etiology, natural history and treatment of hepatocellular carcinoma. Antiviral Res. 2003; 60(2)145–150
   PubMed Web of Science ®Google Scholar
• Tomimatsu M., Ishiguro N., Taniai M., Okuda H., Saito A., Obata H., Yamamoto M., Takasaki K., Nakano M., Hepatitis C. virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 1993; 72(3)683–688
   PubMed Web of Science ®Google Scholar
• Parkin D. M., Srivatanakul P., Khlat M., Chenvidhya D., Chotiwan P., Insiripong S., L'Abbe K. A., Wild C. P. Liver cancer in Thailand. I. a case-control study of cholangiocarcinoma. Int. J. Cancer 1991; 48(3)323–328
   Google Scholar
• Yamamoto M., Takasaki K., Nakano M., Saito A. Minute nodular intrahepatic cholangiocarcinoma. Cancer 1998; 82(11)2145–2149
   PubMed Web of Science ®Google Scholar
• Songsivilai S., Dharakul T., Kanistanon D., Hepatitis C. virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand. Trans. R Soc. Trop. Med. Hyg. 1996; 90(5)505–507
   PubMed Web of Science ®Google Scholar
• Kobayashi M., Ikeda K., Saitoh S. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88(11)2471–2477
   PubMed Web of Science ®Google Scholar
• Sorensen H. T., Friis S., Olsen J. H. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 1998; 28(4)921–925
   PubMed Web of Science ®Google Scholar
• Shin H. R., Lee C. U., Park H. J., Hepatitis B. and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int. J. Epidemiol. 1996; 25(5)933–940
   PubMed Web of Science ®Google Scholar
• Polizos A., Kelekis N., Sinani C. Advanced intrahepatic cholangiocarcinoma in hepatitis C virus related decompensated cirrhosis: Case report and review of the literature. Eur. J. Gastroenterol. Hepatol. 2003; 15(3)331–334
   PubMed Web of Science ®Google Scholar
• Kim C. M., Koike K., Saito I., Miyamura T., Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351(6324)317–320
   PubMed Web of Science ®Google Scholar
• Wang W. L., Gu G. Y., Hu M. Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma. World J. Gastroenterol. 1998; 4(5)392–396
   PubMed Web of Science ®Google Scholar
• Liu X. F., Zou S. Q., Qiu F. Z. Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus. Hepatobiliary Pancreat. Dis. Int. 2003; 2(2)285–289
   PubMedGoogle Scholar
• Khan S. A., Davidson B. R., Goldin R. Guidelines for the diagnosis and treatment of cholangiocarcinoma: Consensus document. Gut 2002; 51: 1–9, (Suppl. VI)
   PubMed Web of Science ®Google Scholar
• Gores G. J. Early detection and treatment of cholangiocarcinoma. Liver Transpl. 2000; 6: 30–34, (Suppl. 2)
   Web of Science ®Google Scholar
• Patel A. H., Harnois D. M., Klee G. G., LaRusso N. F., Gores G. J. The utility of CA 19-9 in the diagnosis of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am. J. Gastroenterol. 2000; 95: 204–207
   PubMed Web of Science ®Google Scholar
• Bruix J., Sherman M., Llovet J. M. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J. Hepatol. 2001; 35: 421–430
   PubMed Web of Science ®Google Scholar
• Danta M., Barnes E., Dusheiko G. The surveillance and diagnosis of hepatocellular carcinoma. Eu.r J. Gastroenterol. Hepatol. 2005; 17: 491–496
   PubMed Web of Science ®Google Scholar
• Natoli G., Avantaggiati M. L., Chirillo P. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX. Mol. Cell Biol. 1994; 14(2)989–998
   PubMed Web of Science ®Google Scholar
• Wang X. W., Gibson M. K., Vermeulen W. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 1995; 55(24)6012–6016
   PubMed Web of Science ®Google Scholar
• Wang X. W., Forrester K., Yeh H., Hepatitis B. virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA 1994; 91(6)2230–2234
   PubMed Web of Science ®Google Scholar
• Vyberg M. The hepatitis-associated bile duct lesion. Liver 1993; 13(6)289–301
   PubMedGoogle Scholar